Over 16 years of rich experience advising CXOs, Promoters and Boards globally. Advised clients across Asia (India, China, Korea, ASEAN, Australia), Europe (Germany, Switzerland, UK), Middle East (Saudi Arabia, UAE) and USA. Deep expertise in pharmaceuticals, working with both innovators and leading generic companies to help set ambitous goals, design winning strategies to achieve them and partnering on implementation to deliver value. Areas of expertise include new market entry strategies, therapy area strategies, building mega brands, profitably accessing "middle of the pyramid" patients, acquisitions & divestures, in & out licensing, marketing spend optimization, designing differentiated services, and leveraging digital capabilities to win. Big-bet decision making when the future is uncertain: Advise top management on taking significant investment decisions in uncertain/ dynamic sectors like oil & gas, technology, infrastructure etc. Advive heads of R&D on maximizing value from their R&D investments by implementing world class processes & tools for R&D portfolio management & decision making. Advise CFOs on optimally allocating capital across diverse capital projects, and CROs in taking a strategic, value focused approach to Enterprise Risk Management.